For cervical adenocarcinoma, due to the limited sample size of patients included in the analysis, the p-value of the km survival curve is not significant, but patients with ATG5 down-expression showed a trend towards a longer survival with no death during the follow-up times (Figure 2H). The gene discussed is ATG5; the disease is cervical adenocarcinoma.